• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌中的交感神经信号传导:连接肿瘤生物学、疼痛与治疗创新

Sympathetic neurosignaling in head and neck squamous cell carcinoma: bridging tumor biology, pain, and therapeutic innovation.

作者信息

Wei Shipeng, Li Yuanyuan, Yang Ruihan, Wang Jing, Huang Fang, Fan Wenguo

机构信息

Department of Anesthesiology, Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University, No. 56 Lingyuanxi Road, Guangzhou, 510080, China.

Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China.

出版信息

Med Oncol. 2025 Jul 15;42(8):334. doi: 10.1007/s12032-025-02911-1.

DOI:10.1007/s12032-025-02911-1
PMID:40663183
Abstract

The sympathetic nervous system (SNS), as an important component of the peripheral nervous system, has emerged as a crucial regulator of solid tumors, from carcinogenesis to progression, metastasis, and pain. This review brings together emerging evidence that SNS signaling is involved in head and neck squamous cell carcinoma (HNSCC) progression, metastasis, and cancer-associated pain. Possible cellular and molecular mechanisms regarding the involvement are also discussed. A systematic literature search was conducted in the PubMed database focusing on SNS, HNSCC, and pain. We found that HNSCC tissues exhibit increased sympathetic nerve innervation compared to healthy tissues. SNS activity modulates key tumor biological processes, including growth and metastasis, angiogenesis, epithelial-mesenchymal transition (EMT), immune responses and apoptosis resistance, through peripheral release of neurotransmitters (primarily noradrenaline) by sympathetic postganglionic neurons or systemic release of epinephrine (Epi) into the circulation by the adrenal medulla. Notably, SNS hyperactivity exacerbates cancer pain via neuro-immune crosstalk, inducing TNF-α, NGF, and BDNF release to sensitize nociceptors. Preclinical studies demonstrate β-blockers suppress HNSCC growth, synergize with chemotherapy/radiotherapy. Therefore, understanding SNS effects on HNSCC biology can offer novel therapeutic targets for this malignancy.

摘要

交感神经系统(SNS)作为外周神经系统的重要组成部分,已成为实体瘤从致癌作用到进展、转移和疼痛的关键调节因子。本综述汇集了新出现的证据,表明SNS信号传导参与头颈部鳞状细胞癌(HNSCC)的进展、转移和癌症相关疼痛。还讨论了有关其参与的可能细胞和分子机制。在PubMed数据库中进行了系统的文献检索,重点关注SNS、HNSCC和疼痛。我们发现,与健康组织相比,HNSCC组织的交感神经支配增加。SNS活性通过交感神经节后神经元外周释放神经递质(主要是去甲肾上腺素)或肾上腺髓质将肾上腺素(Epi)全身释放到循环中,调节关键的肿瘤生物学过程,包括生长和转移、血管生成、上皮-间质转化(EMT)、免疫反应和抗凋亡。值得注意的是,SNS功能亢进通过神经-免疫串扰加剧癌症疼痛,诱导肿瘤坏死因子-α、神经生长因子和脑源性神经营养因子释放,使伤害感受器敏感化。临床前研究表明,β受体阻滞剂可抑制HNSCC生长,与化疗/放疗协同作用。因此,了解SNS对HNSCC生物学的影响可为这种恶性肿瘤提供新的治疗靶点。

相似文献

1
Sympathetic neurosignaling in head and neck squamous cell carcinoma: bridging tumor biology, pain, and therapeutic innovation.头颈部鳞状细胞癌中的交感神经信号传导:连接肿瘤生物学、疼痛与治疗创新
Med Oncol. 2025 Jul 15;42(8):334. doi: 10.1007/s12032-025-02911-1.
2
IGF2BP1 promotes the progression of head and neck squamous cell carcinoma by activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.胰岛素样生长因子2 mRNA结合蛋白1通过激活PI3K/AKT/mTOR信号通路和诱导上皮-间质转化促进头颈部鳞状细胞癌进展。
World J Surg Oncol. 2025 Jul 14;23(1):277. doi: 10.1186/s12957-025-03929-5.
3
Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells.头颈部鳞状细胞癌的单细胞分子剖析揭示了与循环肿瘤细胞相关的五条失调信号通路。
Cancer Control. 2024 Jan-Dec;31:10732748241251571. doi: 10.1177/10732748241251571.
4
ADAM22 enhances lymphatic metastasis and epithelial-mesenchymal transition in head and neck squamous cell carcinoma cells through integrin signaling.ADAM22通过整合素信号传导增强头颈部鳞状细胞癌细胞的淋巴转移和上皮-间质转化。
Med Oncol. 2025 Jun 3;42(7):236. doi: 10.1007/s12032-025-02789-z.
5
FAM83A Promotes the Progression and Metastasis of Head and Neck Squamous Cell Carcinoma via PKM2-Mediated Aerobic Glycolysis.FAM83A通过PKM2介导的有氧糖酵解促进头颈部鳞状细胞癌的进展和转移。
FASEB J. 2025 Jul 31;39(14):e70796. doi: 10.1096/fj.202500989RR.
6
ULBP2 promotes progression of head and neck squamous cell carcinoma by modulating MAPK signaling pathway.ULBP2通过调节丝裂原活化蛋白激酶(MAPK)信号通路促进头颈部鳞状细胞癌的进展。
J Stomatol Oral Maxillofac Surg. 2025 Jun;126(3S):102204. doi: 10.1016/j.jormas.2024.102204. Epub 2024 Dec 18.
7
MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathway.MRPL21-PARP1轴通过PI3K/AKT/mTOR信号通路抑制自噬,从而促进头颈部鳞状细胞癌对顺铂的耐药性。
J Exp Clin Cancer Res. 2025 Jul 26;44(1):221. doi: 10.1186/s13046-025-03482-9.
8
Perineural Invasion Is Associated With Function-evoked Pain and Altered Extracellular Matrix in Patients With Head and Neck Squamous Cell Carcinoma.神经周围侵犯与头颈部鳞状细胞癌患者的功能诱发疼痛和细胞外基质改变有关。
J Pain. 2024 Oct;25(10):104615. doi: 10.1016/j.jpain.2024.104615. Epub 2024 Jun 25.
9
Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer.P-钙黏蛋白和c-Met的双重阻断协同抑制头颈癌的生长。
Cell Oncol (Dordr). 2025 May 20. doi: 10.1007/s13402-025-01061-w.
10
LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC.LiGeR-HN关于培托西单抗+帕博利珠单抗和培托西单抗单药治疗复发性或转移性头颈部鳞状细胞癌的III期试验。
Future Oncol. 2025 Jul;21(16):2007-2016. doi: 10.1080/14796694.2025.2511470. Epub 2025 Jun 13.

本文引用的文献

1
Neurodegeneration of local sympathetic inputs promotes colorectal cancer progression.局部交感神经输入的神经变性促进结直肠癌进展。
Cancer Lett. 2025 Aug 10;625:217817. doi: 10.1016/j.canlet.2025.217817. Epub 2025 May 22.
2
The muscle stem cell case of Benjamin Button: rejuvenating muscle regenerative capacity through nutraceuticals.肌肉干细胞的本杰明·巴顿奇事:通过营养保健品恢复肌肉再生能力。
J Clin Invest. 2024 Dec 16;134(24):e185054. doi: 10.1172/JCI185054.
3
Identification and validation of M2 macrophage-related gene signature as a novel prognostic model for head and neck squamous cell carcinoma.
鉴定和验证 M2 巨噬细胞相关基因特征作为头颈部鳞状细胞癌的新型预后模型。
Sci Rep. 2024 Oct 25;14(1):25338. doi: 10.1038/s41598-024-76866-0.
4
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
5
Expression of β- and β-adrenergic receptors in oral squamous cell carcinoma and their association with psychological and clinical factors.β-和β-肾上腺素能受体在口腔鳞状细胞癌中的表达及其与心理和临床因素的关系。
Arch Oral Biol. 2024 Jun;162:105939. doi: 10.1016/j.archoralbio.2024.105939. Epub 2024 Feb 29.
6
Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs.感觉神经释放的降钙素基因相关肽通过抑制肿瘤浸润淋巴细胞来促进头颈部鳞状细胞癌的肿瘤生长。
Med. 2024 Mar 8;5(3):254-270.e8. doi: 10.1016/j.medj.2024.02.002. Epub 2024 Feb 28.
7
The β-adrenergic receptor links sympathetic nerves to T cell exhaustion.β-肾上腺素能受体将交感神经与 T 细胞耗竭联系起来。
Nature. 2023 Oct;622(7982):383-392. doi: 10.1038/s41586-023-06568-6. Epub 2023 Sep 20.
8
β-AR inhibition enhances EGFR antibody efficacy hampering the oxidative stress response machinery.β-AR 抑制增强了 EGFR 抗体的疗效,从而抑制了氧化应激反应机制。
Cell Death Dis. 2023 Sep 19;14(9):613. doi: 10.1038/s41419-023-06129-9.
9
M2 macrophage polarization: a potential target in pain relief.M2 巨噬细胞极化:缓解疼痛的潜在靶点。
Front Immunol. 2023 Aug 29;14:1243149. doi: 10.3389/fimmu.2023.1243149. eCollection 2023.
10
Comprehensive Geriatric Assessment and Quality of Life Aspects in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).复发性/转移性头颈部鳞状细胞癌(HNSCC)患者的综合老年评估与生活质量方面
J Clin Med. 2023 Sep 3;12(17):5738. doi: 10.3390/jcm12175738.